Search Results - "de Jesus, Marcelo M."

Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis by Vale, Danniele L, Freitas, Camila S, Martins, Vívian T, Moreira, Gabriel J L, Machado, Amanda S, Ramos, Fernanda F, Pereira, Isabela A G, Bandeira, Raquel S, de Jesus, Marcelo M, Tavares, Grasiele S V, Ludolf, Fernanda, Chávez-Fumagalli, Miguel A, Galdino, Alexsandro S, Fujiwara, Ricardo T, Bueno, Lílian L, Roatt, Bruno M, Christodoulides, Myron, Coelho, Eduardo A F, Lage, Daniela P

“…Visceral leishmaniasis (VL) in the Americas is a chronic systemic disease caused by infection with parasites. The toxicity of antileishmanial drugs, long…”
Get full text

Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with Leishmania amazonensis by Soyer, Tauane G, Ramos, Fernanda F, Pereira, Isabela A G, Lage, Daniela P, Bandeira, Raquel S, de Jesus, Marcelo M, Costa, Guilherme P, Machado, Amanda S, Freitas, Camila S, Vale, Danniele L, Martins, Vívian T, Galdino, Alexsandro S, Chávez-Fumagalli, Miguel A, Menezes-Souza, Daniel, Duarte, Mariana C, Roatt, Bruno M, Coelho, Eduardo A F, Tavares, Grasiele S V

“…can cause cutaneous and visceral clinical manifestations of leishmaniasis in infected hosts. Once the treatment against disease is toxic, presents high cost,…”
Get full text

The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice by Lage, Daniela P., Martins, Vívian T., Vale, Danniele L., Freitas, Camila S., Pimenta, Breno L., Moreira, Gabriel J.L., Ramos, Fernanda F., Pereira, Isabela A.G., Bandeira, Raquel S., de Jesus, Marcelo M., Ludolf, Fernanda, Tavares, Grasiele S.V., Chávez-Fumagalli, Miguel A., Roatt, Bruno M., Christodoulides, Myron, Coelho, Eduardo A.F.

“…•Combination of rLiHyp1, MPLA and AmpB was an effective immunotherapy in L. infantum-infected BALB/c. mice.•A Th1-type immune response was developed after…”
Get full text

In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis by Freitas, Camila S., Santiago, Samira S., Lage, Daniela P., Antinarelli, Luciana M.R., Oliveira, Fabrício M., Vale, Danniele L., Martins, Vívian T., Magalhaes, Lícia N.D., Bandeira, Raquel S., Ramos, Fernanda F., Pereira, Isabela A.G., de Jesus, Marcelo M., Ludolf, Fernanda, Tavares, Grasiele S.V., Costa, Adilson V., Ferreira, Rafaela S., Coimbra, Elaine S., Teixeira, Róbson R., Coelho, Eduardo A.F.

“…The treatment against leishmaniasis presents problems, mainly due to their toxicity of the drugs, high cost and/or by the emergence of parasite resistant…”
Get full text

Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with ILeishmania amazonensis/I by Soyer, Tauane G, Ramos, Fernanda F, Pereira, Isabela A. G, Lage, Daniela P, Bandeira, Raquel S, de Jesus, Marcelo M, Costa, Guilherme P, Machado, Amanda S, Freitas, Camila S, Vale, Danniele L, Ma, Galdino, Alexsandro S, Chávez-Fumagalli, Miguel A, Menezes-Souza, Daniel, Duarte, Mariana C, Roatt, Bruno M, Coelho, Eduardo A. F, Tavares, Grasiele S. V

“…Leishmania amazonensis can cause cutaneous and visceral clinical manifestations of leishmaniasis in infected hosts. Once the treatment against disease is…”
Get full text